Autologous Extracellular Matrix-Based Cell-Free Therapy for Tissue Regeneration Through Trem2⁺ Macrophages Mediated Angiogenesis

Abstract

The extracellular matrix (ECM) is vital for tissue regeneration and remodeling by providing structural support and regulating cell behavior. Bioactive membranes derived from decellularized ECM show promising regenerative potential in many fields. However, they still face challenges such as immune rejection, structural disparities, and high costs associated with human-derived materials. These issues hinder their widespread clinical application and limit their adaptability to personalized treatments. Further research is needed to improve the safety, efficacy, and accessibility of ECM-based materials. This study develops an autologous ECM-based membrane, termed adipose-derived matrix film (ADF), using a simple physical method inspired by traditional “papermaking.” ADF exhibits favorable biological activity and mechanical strength, essential for tissue regeneration. Its production is efficient, facilitating clinical translation. Additionally, ADF can be stored long-term at low temperatures, enabling the establishment of an “ECM bank” for personalized medicine. As a cell-free therapy, ADF enhances soft tissue regeneration and wound healing, with Trem2⁺ macrophages playing a key role in neovascularization. We introduce a novel autologous adipose ECM-derived bio-membrane, offering new perspectives on ECM preservation and Trem2⁺ macrophage-mediated regeneration. These findings significantly advance cell-free regenerative medicine and redefine fundamental mechanisms of tissue repair and vascular restoration.

Keywords

adipose-derived matrix film / angiogenesis / cell-free therapy / extracellular matrix / tissue regeneration

References

[1] A. Naba, “Mechanisms of Assembly and Remodelling of the Extracellular Matrix,” Nature Reviews Molecular Cell Biology 25 (2024): 865–885, https://doi.org/10.1038/s41580-024-00767-3.

[2] A. Sainio and H. Järveläinen, “Extracellular Matrix-Cell Interactions: Focus on Therapeutic Applications,” Cellular Signalling 66 (2020): 109487, https://doi.org/10.1016/j.cellsig.2019.109487.

[3] M. R. Chastney, J. Kaivola, V.-M. Leppänen, and J. Ivaska, “The Role and Regulation of Integrins in Cell Migration and Invasion,” Nature Reviews Molecular Cell Biology 26 (2025): 147–167, https://doi.org/10.1038/s41580-024-00777-1.

[4] W. He, Q. Wang, X. Tian, and G. Pan, “Recapitulating Dynamic ECM Ligand Presentation at Biomaterial Interfaces: Molecular Strategies and Biomedical Prospects,” Exploration (Beijing, China) 2 (2022): 20210093.

[5] A. D. McInnes, M. A. J. Moser, and X. Chen, “Preparation and Use of Decellularized Extracellular Matrix for Tissue Engineering,” Journal of Functional Biomaterials 13, no. 4 (2022): 240, https://doi.org/10.3390/jfb13040240.

[6] A. A. Golebiowska, J. T. Intravaia, V. M. Sathe, S. G. Kumbar, and S. P. Nukavarapu, “Decellularized Extracellular Matrix Biomaterials for Regenerative Therapies: Advances, Challenges and Clinical Prospects,” Bioactive Materials 32 (2024): 98–123, https://doi.org/10.1016/j.bioactmat.2023.09.017.

[7] N. N. Giang, X. T. Trinh, J. Han, et al., “Effective Decellularization of Human Skin Tissue for Regenerative Medicine by Supercritical Carbon Dioxide Technique,” Journal of Tissue Engineering and Regenerative Medicine 16 (2022): 1196–1207, https://doi.org/10.1002/term.3359.

[8] L. L. Tang, H. Liu, and Y. L. Wang, C. Y. Xian, and A. H. Su, “Evaluation of the Biocompatibility of Acellular Porcine Dermis,” Colloids and Surfaces B, Biointerfaces 57 (2007): 215–218, https://doi.org/10.1016/j.colsurfb.2007.02.009.

[9] J. Okadome, K. Morisaki, D. Matsuda, et al., “Comparison of Early Outcomes in Patients Who Underwent Common Femoral Thromboendarterectomy With Vein Versus Bovine Pericardial Patches,” Annals of Vascular Surgery 110 (2025): 498–504, https://doi.org/10.1016/j.avsg.2024.08.032.

[10] S. Doudi, M. Barzegar, E. A. Taghavi, et al., “Applications of Acellular human Amniotic Membrane in Regenerative Medicine,” Life Science 310 (2022): 121032, https://doi.org/10.1016/j.lfs.2022.121032.

[11] R. Mazloomnejad, A. Babajani, M. Kasravi, et al., “Angiogenesis and Re-endothelialization in Decellularized Scaffolds: Recent Advances and Current Challenges in Tissue Engineering,” Frontiers in Bioengineering and Biotechnology 11 (2023): 1103727, https://doi.org/10.3389/fbioe.2023.1103727.

[12] Y. T. Song, P. C. Liu, X. L. Zhou, et al., “Extracellular Matrix-Based Biomaterials in Burn Wound Repair: A Promising Therapeutic Strategy,” International Journal of Biological Macromolecules 283 (2024): 137633, https://doi.org/10.1016/j.ijbiomac.2024.137633.

[13] C. Dai, S. Shih, and A. Khachemoune, “Skin Substitutes for Acute and Chronic Wound Healing: An Updated Review,” Journal of Dermatological Treatment 31 (2020): 639–648, https://doi.org/10.1080/09546634.2018.1530443.

[14] A. Alsaif, M. Karam, A. Hayre, A. Abul, A. Aldubaikhi, and N. Kahlar, “Full Thickness Skin Graft Versus Split Thickness Skin Graft in Paediatric Patients With Hand Burns: Systematic Review and Meta-Analysis,” Burns: Journal of the International Society for Burn Injuries 49 (2023): 1017–1027, https://doi.org/10.1016/j.burns.2022.09.010.

[15] C. Davis, C. Boyd, D. A. Mateo de Acosta Andino, et al., “Dermal Autografts in Breast Reconstruction,” Annals of Plastic Surgery 84 (2020): 618–622, https://doi.org/10.1097/SAP.0000000000002128.

[16] M. E. Bock, R. Nagle, M. Soyster, et al., “Robotic Sacral Colpopexy Using Autologous Fascia Lata Compared With Mesh,” Journal of Endourology 35 (2021): 801–807, https://doi.org/10.1089/end.2020.0537.

[17] J. S. Shaw, L. R. Wilson, M. Z. Wilson, S. J. Ivatury, and K. Strohbehn, “Autologous Fascia Lata for Combined Sacrocolpopexy and Rectopexy,” Female Pelvic Medicine & Reconstructive Surgery 27 (2021): e484–e486, https://doi.org/10.1097/SPV.0000000000001038.

[18] L. Matak, J. Baekelandt, M. Šimičević, M. Matak, M. Mikuš, and S. Orešković, “Comparison Between Fascia Lata and Rectus Fascia in Treatment of Pelvic Organ Prolapse: A Systematic Review,” Archives of Gynecology and Obstetrics 309 (2024): 2395–2400, https://doi.org/10.1007/s00404-024-07531-0.

[19] A. L. Strong, P. S. Cederna, J. P. Rubin, S. R. Coleman, and B. Levi, “The Current State of Fat Grafting,” Plastic and Reconstructive Surgery 136 (2015): 897–912, https://doi.org/10.1097/PRS.0000000000001590.

[20] J. Liu, J. Wang, Q. Zhang, F. Lu, and J. Cai, “Clinical, Histologic, and Transcriptomic Evaluation of Sequential Fat Grafting for Morphea,” JAMA Dermatology 160 (2024): 425, https://doi.org/10.1001/jamadermatol.2023.5908.

[21] X. Rong, J. Tang, J. Yang, et al., “Immediate SVF-Gel Injection Reduced Incision Scar Formation: A Prospective, Double-Blind, Randomized, Self-Control Trial,” Aesthetic Plastic Surgery 48 (2024): 3147–3153, https://doi.org/10.1007/s00266-024-04126-7.

[22] A. Wongkietkachorn and N. Wongkietkachorn, “Efficacy of Nanofat in Wound Healing: A Prospective, Double-Blinded, Randomized Controlled Trial,” Plastic and Reconstructive Surgery ahead of print, October 7, 2025, https://doi.org/10.1097/PRS.0000000000012507.

[23] M. B. Akdogan, Y. P. Incetas, G. Akoglu, and E. Caliskan, “Autologous Microfat and Nanofat Grafting Combined With Platelet-Rich Fibrin in Early Treatment of Atrophic Facial Scars,” Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery ahead of print, September 24, 2025, https://doi.org/10.1097/DSS.0000000000004877.

[24] D. C. Andersen, F. A. Bjerre, M. G. Jørgensen, J. A. Sørensen, and C. H. Jensen, “Clinical Outcome Is Unlinked to Injection of Adipose-Derived Regenerative Cells in the Axilla of Breast Cancer-Related Lymphedema Patients,” Stem Cell Research & Therapy 15 (2024): 426, https://doi.org/10.1186/s13287-024-04037-z.

[25] D. Pally and A. Naba, “Extracellular Matrix Dynamics: A Key Regulator of Cell Migration Across Length-scales and Systems,” Current Opinion in Cell Biology 86 (2024): 102309, https://doi.org/10.1016/j.ceb.2023.02309.

[26] M. Ahmed and C. Ffrench-Constant, “Extracellular Matrix Regulation of Stem Cell Behavior,” Current Stem Cell Reports 2 (2016): 197–206, https://doi.org/10.1007/s40778-016-0056-2.

[27] P. Kanchanawong and D. A. Calderwood, “Organization, Dynamics and Mechanoregulation of Integrin-Mediated Cell–ECM Adhesions,” Nature Reviews Molecular Cell Biology 24 (2023): 142–161, https://doi.org/10.1038/s41580-022-00531-5.

[28] M. Dibus, O. Joshi, and J. Ivaska, “Novel Tools to Study Cell-ECM Interactions, Cell Adhesion Dynamics and Migration,” Current Opinion in Cell Biology 88 (2024): 102355, https://doi.org/10.1016/j.ceb.2024.102355.

[29] C. Bonnans, J. Chou, and Z. Werb, “Remodelling the Extracellular Matrix in Development and Disease,” Nature Reviews Molecular Cell Biology 15 (2014): 786–801, https://doi.org/10.1038/nrm3904.

[30] Y. Zhang, Y. He, S. Bharadwaj, et al., “Tissue-Specific Extracellular Matrix Coatings for the Promotion of Cell Proliferation and Maintenance of Cell Phenotype,” Biomaterials 30 (2009): 4021–4028, https://doi.org/10.1016/j.biomaterials.2009.04.005.

[31] J. Wei, D. T. Baptista-Hon, Z. Wang, et al., “Bioengineered Human Tissue Regeneration and Repair Using Endogenous Stem Cells,” Cell Reports Medicine 4 (2023): 101156, https://doi.org/10.1016/j.xcrm.2023.101156.

[32] J. Zarubova, M. M. Hasani-Sadrabadi, R. Ardehali, and S. Li, “Immunoengineering Strategies to Enhance Vascularization and Tissue Regeneration,” Advanced Drug Delivery Reviews 184 (2022): 114233, https://doi.org/10.1016/j.addr.2022.114233.

[33] B. Jia, H. Huang, Z. Dong, et al., “Degradable Biomedical Elastomers: Paving the Future of Tissue Repair and Regenerative Medicine,” Chemical Society Reviews 53 (2024): 4086–4153, https://doi.org/10.1039/D3CS00923H.

[34] S. Moon, J. Hong, S. Go, and B. S. Kim, “Immunomodulation for Tissue Repair and Regeneration,” Tissue Engineering and Regenerative Medicine 20 (2023): 389–409, https://doi.org/10.1007/s13770-023-00525-0.

[35] M. D. Park, A. Silvin, F. Ginhoux, and M. Merad, “Macrophages in Health and Disease,” Cell 185 (2022): 4259–4279, https://doi.org/10.1016/j.cell.2022.10.007.

[36] J. Ma and C. Wu, “Bioactive Inorganic Particles-Based Biomaterials for Skin Tissue Engineering,” Exploration (Beijing, China) 2 (2022): 20210083.

[37] B. R. Freedman, C. Hwang, S. Talbot, B. Hibler, S. Matoori, and D. J. Mooney, “Breakthrough Treatments for Accelerated Wound Healing,” Science Advances 9 (2023): eade7007, https://doi.org/10.1126/sciadv.ade7007.

[38] D. Henn, K. Chen, T. Fehlmann, et al., “Xenogeneic Skin Transplantation Promotes Angiogenesis and Tissue Regeneration Through Activated Trem2⁺ Macrophages,” Science Advances 7 (2021): eabi4528, https://doi.org/10.1126/sciadv.abi4528.

[39] L. Zhou, Y. Lu, X. Qiu, et al., “Lipid Droplet Efferocytosis Attenuates Proinflammatory Signaling in Macrophages via TREM2- and MS4A7-dependent Mechanisms,” Cell Reports 44 (2025): 115310, https://doi.org/10.1016/j.celrep.2025.115310.

[40] O. I. Shevchuk, V. V. Korcheva, N. S. Moskalenko, V. M. Kyryk, K. V. Kot, and D. S. Krasnienkov, “Application of Decellularization Methods for Scaffold Production: Advantages, Disadvantages, Biosafety and Modifications,” Frontiers in Bioengineering and Biotechnology 13 (2025): 1621641, https://doi.org/10.3389/fbioe.2025.1621641.

[41] R. Liang, R. Pan, L. He, et al., “Decellularized Extracellular Matrices for Skin Wound Treatment,” Materials (Basel, Switzerland) 18 (2025): 2752, https://doi.org/10.3390/ma18122752.

[42] M. R. Hicks and A. D. Pyle, “The Emergence of the Stem Cell Niche,” Trends in Cell Biology 33 (2023): 112–123, https://doi.org/10.1016/j.tcb.2022.07.003.

[43] F. K. Lewns, O. Tsigkou, L. R. Cox, R. D. Wildman, L. M. Grover, and G. Poologasundarampillai, “Hydrogels and Bioprinting in Bone Tissue Engineering: Creating Artificial Stem-Cell Niches for In Vitro Models,” Advanced Materials (Deerfield Beach, Fla) 35 (2023): e2301670, https://doi.org/10.1002/adma.202301670.

[44] E. Chrysostomou and P. Mourikis, “The Extracellular Matrix Niche of Muscle Stem Cells,” Current Topics in Developmental Biology 158 (2024): 123–150.

[45] S. Zhang, Y. Guo, Y. Lu, F. Liu, B. C. Heng, and X. Deng, “The Considerations on Selecting the Appropriate Decellularized ECM for Specific Regeneration Demands,” Materials Today Bio 29 (2024): 101301, https://doi.org/10.1016/j.mtbio.2024.101301.

[46] T. K. Rajab, T. J. O'Malley, and V. Tchantchaleishvili, “Decellularized Scaffolds for Tissue Engineering: Current Status and Future Perspective,” Artificial Organs 44 (2020): 1031–1043, https://doi.org/10.1111/aor.13701.

[47] M. M. Duarte, I. V. Silva, A. R. Eisenhut, N. Bionda, A. R. C. Duarte, and A. L. Oliveira, “Contributions of Supercritical Fluid Technology for Advancing Decellularization and Postprocessing of Viable Biological Materials,” Materials Horizons 9 (2022): 864–891, https://doi.org/10.1039/D1MH01720A.

[48] L. T. T. Le, N. C. Pham, X. T. Trinh, et al., “Supercritical Carbon Dioxide Decellularization of Porcine Nerve Matrix for Regenerative Medicine,” Tissue Engineering Part A 30 (2024): 447–459, https://doi.org/10.1089/ten.tea.2023.0228.

[49] M. Brown, J. Li, C. Moraes, M. Tabrizian, and N. Y. K. Li-Jessen, “Decellularized Extracellular Matrix: New Promising and Challenging Biomaterials for Regenerative Medicine,” Biomaterials 289 (2022): 121786, https://doi.org/10.1016/j.biomaterials.2022.121786.

[50] F. C. Paccola Mesquita, C. Hochman-Mendez, J. Morrissey, L. C. Sampaio, and D. A. Taylor, “Laminin as a Potent Substrate for Large-Scale Expansion of Human Induced Pluripotent Stem Cells in a Closed Cell Expansion System,” Stem Cells International 2019 (2019): 9704945, https://doi.org/10.1155/2019/9704945.

[51] S. H. Mahfouzi, S. H. Safiabadi Tali, and G. Amoabediny, “Decellularized Human-Sized Pulmonary Scaffolds for Lung Tissue Engineering: A Comprehensive Review,” Regenerative Medicine 16 (2021): 757–774, https://doi.org/10.2217/rme-2020-0152.

[52] Z. Wu, H. Huang, Y. Shi, et al., “Clinical Study of Matrix Vascular Component Gel Combined With Vacuum Sealing Drainage Technique in Chronic Wounds,” Biomedical Materials (Bristol, England) 19 (2024): 065029, https://doi.org/10.1088/1748-605X/ad80ed.

[53] E. Behrangi, S. Moradi, M. Ghassemi, et al., “The Investigation of the Efficacy and Safety of Stromal Vascular Fraction in the Treatment of Nanofat-Treated Acne Scar: A Randomized Blinded Controlled Clinical Trial,” Stem Cell Research & Therapy 13 (2022): 298, https://doi.org/10.1186/s13287-022-02957-2.

[54] Y. Li, P. Zhang, X. Zhang, et al., “Adipose Matrix Complex: A High-Rigidity Collagen-Rich Adipose-Derived Material for Fat Grafting,” Aging 13 (2021): 14910–14923, https://doi.org/10.18632/aging.203120.

[55] X. Li, G. Zhang, M. Wang, et al., “Comparison of Stromal Vascular Fraction Cell Composition Between Coleman Fat and Extracellular Matrix/Stromal Vascular Fraction Gel,” Adipocyte 13 (2024): 2360037, https://doi.org/10.1080/21623945.2024.2360037.

[56] A. Gefen, P. Alves, D. Beeckman, et al., “Fluid Handling by Foam Wound Dressings: From Engineering Theory to Advanced Laboratory Performance Evaluations,” International Wound Journal 21 (2024): e14674, https://doi.org/10.1111/iwj.14674.

[57] C. Horn, N. Uzor, A. Fierro, M. Abeshouse, K. Ray, and J. C. Lantis 2nd, “Implantable Biologics for Soft Tissue Surgery Reinforcement,” Surgical Technology International 42 (2023): 31–44.

[58] K. Samuels, E. Millet, and L. Wong, “Efficacy of Acellular Dermal Matrix Type in Treatment of Capsular Contracture in Breast Augmentation: A Systematic Review and Meta-Analysis,” Aesthetic Surgery Journal 44 (2023): 26–35, https://doi.org/10.1093/asj/sjad265.

[59] L. Tavelli, S. Barootchi, G. Rasperini, and W. V. Giannobile, “Clinical and Patient-Reported Outcomes of Tissue Engineering Strategies for Periodontal and Peri-Implant Reconstruction,” Periodontology 2000 91 (2023): 217–269, https://doi.org/10.1111/prd.12446.

[60] P. K. Farahani, “Application of Tissue Engineering and Biomaterials in Nose Surgery,” JPRAS open 40 (2024): 262–272, https://doi.org/10.1016/j.jpra.2023.11.001.

[61] S. M. Hussein, B. A. Sharaf, S. Mardini, and W. Gibreel, “Advancing Auricular Reconstruction: The Evolution and Outcomes of Auricular Reconstruction Using a Porous Polyethylene (PPE) Framework,” Journal of Clinical Medicine 14 (2025): 4116, https://doi.org/10.3390/jcm14124116.

[62] K. Turlakiewicz, M. Puchalski, I. Krucinska, and W. J. M. Sujka, “The Role of Mesh Implants in Surgical Treatment of Parastomal Hernia,” Materials (Basel) 14 (2021): 1062, https://doi.org/10.3390/ma14051062.

[63] M. H. Gold, A. Andriessen, D. Day, et al., “The Role of a Shelf-Ready, Human-Derived, Soft Tissue Injectable Adipose Matrix for Facial Volume Correction,” Journal of Cosmetic Dermatology 19 (2020): 2476–2483, https://doi.org/10.1111/jocd.13680.

[64] C. Liu, M. Pei, Q. Li, and Y. Zhang, “Decellularized Extracellular Matrix Mediates Tissue Construction and Regeneration,” Frontiers of Medicine 16 (2022): 56–82, https://doi.org/10.1007/s11684-021-0900-3.

[65] H. Fujiwara, “Dynamic Duo: Cell–Extracellular Matrix Interactions in Hair Follicle Development and Regeneration,” Developmental Biology 516 (2024): 20–34, https://doi.org/10.1016/j.ydbio.2024.07.012.

[66] Z. Liu, X. Wan, Z. L. Wang, and L. Li, “Electroactive Biomaterials and Systems for Cell Fate Determination and Tissue Regeneration: Design and Applications,” Advanced Materials (Deerfield Beach, Fla) 33, no. 32 (2021): 2007429, https://doi.org/10.1002/adma.202007429.

[67] C. Alvarez-Lorenzo, A. Ramirez-Romero, D. Peixoto, M. Vivero-Lopez, I. Rodríguez-Moldes, and A. Concheiro, “Biomimetic Cell Membrane-Coated Scaffolds for Enhanced Tissue Regeneration,” Advanced Materials 37 (2025): 2507084, https://doi.org/10.1002/adma.202507084.

[68] A. R. Muñoz-Rojas and D. Mathis, “Tissue Regulatory T Cells: Regulatory Chameleons,” Nature Reviews Immunology 21 (2021): 597–611, https://doi.org/10.1038/s41577-021-00519-w.

[69] L. F. Loffredo, T. M. Savage, O. R. Ringham, and N. Arpaia, “Treg–Tissue Cell Interactions in Repair and Regeneration,” Journal of Experimental Medicine 221 (2024): e20231244, https://doi.org/10.1084/jem.20231244.

[70] E. A. Zheremyan, A. S. Ustiugova, N. M. Karamushka, et al., “Breg-Mediated Immunoregulation in the Skin,” International Journal of Molecular Sciences 25, no.1 (2024): 583, https://doi.org/10.3390/ijms25010583.

[71] S. Dikiy and A. Y. Rudensky, “Principles of Regulatory T Cell Function,” Immunity 56 (2023): 240–255, https://doi.org/10.1016/j.immuni.2023.01.004.

[72] J. Chuprin, H. Buettner, M. O. Seedhom, et al., “Humanized Mouse Models for Immuno-oncology Research,” Nature Reviews Clinical Oncology 20 (2023): 192–206, https://doi.org/10.1038/s41571-022-00721-2.

[73] A. T. Lasher, H. Srivastava, and L. Y. Sun, “Insights Into the Role of Glucagon Receptor Signaling in Metabolic Regulation From Pharmacological Inhibition and Tissue-Specific Knockout Models,” Biomedicines 10 (2022): 1097, https://doi.org/10.3390/biomedicines10081907.

[74] B. A. Melnick, A. Abu-Romman, K. S. Fine, et al., “Decellularized Adipose Matrix for Soft Tissue Regeneration: Enhancing Angiogenesis and Adipogenesis,” Tissue Engineering Part B, Reviews ahead of print 32, no. 1 (2026): 29–43, https://doi.org/10.1089/ten.teb.2024.0321.

[75] C. Xiong, W. Yao, R. Tao, et al., “Application of Decellularized Adipose Matrix as a Bioscaffold in Different Tissue Engineering,” Aesthetic Plastic Surgery 48 (2024): 1045–1053, https://doi.org/10.1007/s00266-023-03608-4.

[76] M. Li, X. Li, B. Liu, et al., “Time-Resolved Extracellular Matrix Atlas of the Developing Human Skin Dermis,” Frontiers in Cell and Developmental Biology 9 (2021): 783456, https://doi.org/10.3389/fcell.2021.783456.

RIGHTS & PERMISSIONS

2026 The Author(s). Exploration published by Henan University and John Wiley & Sons Australia, Ltd.